Celebrating 25 Years of Scoop
Special: Up To 25% Off Scoop Pro Learn More

Myeloma New Zealand - Latest News [Page 1]

Potential For New And Expanded Myeloma Medicines Positive For Patients, But It’s Not Enough

Tuesday, 23 April 2024, 8:09 pm | Myeloma New Zealand

While today’s announcement is exciting, we remain concerned about how long it takes to get medicines funded in New Zealand. The application for lenalidomide for first line treatment was submitted in April 2016; the application for pomalidomide was ... More >>

Myeloma NZ & Leukaemia & Blood Cancer NZ welcome potential for new and expanded medicines access, but more is needed

Thursday, 24 August 2023, 7:26 pm | Myeloma New Zealand

“We are very pleased Pharmac has today announced a Request for Proposal (RFP) for the supply of lenalidomide and pomalidomide to treat multiple myeloma,” says Barbara Horne, Chair of Myeloma New Zealand. “While lenalidomide is already available ... More >>

15 Year Cancer Thriver Rides Around New Zealand Raising Money And Awareness For Blood Cancer Multiple Myeloma

Thursday, 4 May 2023, 6:00 pm | Myeloma New Zealand

American multiple myeloma patient Andrew Sninsky, 75, is cycling around New Zealand to raise awareness of a cancer without a cure. Myeloma is a blood cancer of the plasma cells which are white blood cells in the bone marrow that make antibodies. Myeloma ... More >>

Cancer Agency Report Duplicates Pharmac Role

Thursday, 28 April 2022, 5:01 pm | Myeloma New Zealand

The Cancer Control Agency’s analysis of the gap between Australia and New Zealand in funding 18 selected medicines with substantial clinical benefit is a welcome way of drawing attention to the plight of NZ cancer patients desperate for treatments ... More >>

Patient advocacy group presents to Health Select Committee

Wednesday, 7 August 2019, 9:35 am | Myeloma New Zealand

Dr Ken Romeril, chief executive, Myeloma New Zealand, is appearing today before the Health Select Committee in support of their submission asking for funding of six life-extending treatments for multiple myeloma patients. More >>

New Zealand falling behind rest of world in cancer treatment

Wednesday, 26 June 2019, 10:00 am | Myeloma New Zealand

The management of New Zealand’s most common blood cancer, myeloma, is falling behind the rest of the world, putting lives at unnecessary risk of this incurable but treatable disease. More >>

Blood cancer patients advocate pleads for treatment funding

Wednesday, 8 May 2019, 9:26 am | Myeloma New Zealand

Patient advocacy group Myeloma New Zealand has joined forces with other patient groups to petition Parliament to approve funding for state-of-the-art cancer treatments for New Zealanders. Myeloma NZ is petitioning for funding for a suite of six life-extending ... More >>

Lack of effective treatments for blood cancer patients

Thursday, 12 April 2018, 1:15 pm | Myeloma New Zealand

Lack of access to effective treatments is forcing blood cancer patients to take desperate measures More >>




Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.